Knight Therapeutics Inc opened trading today at $5.30 and closed at $5.32. prices ranged from $5.26 to $5.36.

The price decreased -0.37% from the previous day's close of $5.34.

During the day across North America, the TSX Composite closed 0.17% at 22112.46, the S&P 500 closed 0.11% at 5211.49, the Dow Jones Industrial Average closed -0.11% at 39127.14 and the Nasdaq Composite closed 0.23% at 16277.46.

Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.

A total of 63,116 shares was traded during the session, with total trades of 251, while having an average volume of 46,934 in the last five days.

The TSX overall saw 1,535 price advancers against 3,670 declines and 135 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $5.75 (January 22,2024) and low as $4.35 (October 23,2023). Moreover, in the last 52 weeks, Knight Therapeutics Inc's shares have advanced 16.41%, while they have advanced 2.50% year-to-date.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $540.25 million on a float of 101,170 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Currently, Knight Therapeutics Inc has an average recommendation of "Moderate Buy" based on 4.00 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..